Fibromyalgia (FM) is estimated to affect between 2 to 4% of the world's population and is the second most commonly diagnosed disorder in rheumatology clinics, second only to osteoarthritis.

More Information

May 6, 2008

CYPRESS BIOSCIENCE TO PRESENT AT THE NEUROTECH INDUSTRY INVESTING & PARTNERING CONFERENCE

May 1, 2008

CYPRESS BIOSCIENCE TO PRESENT AT DEUTSCHE BANK HEALTH CARE CONFERENCE

March 17, 2008

CYPRESS BIOSCIENCE ANNOUNCES FOURTH QUARTER AND FISCAL YEAR END 2007 RESULTS